Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical Technologies, Inc. is based in Newtown, Pennsylvania.
Info & Links
CEO
Dane C. Andreeff
Headquarters
642 NEWTOWN YARDLEY ROAD, SUITE 100 NEWTOWN, PA 18940, UNITED STATES
Solana Company Class A Common Stock (DE) Statistics
Valuation Measures
Market Capitalization2
175.08M
Enterprise Value
51.03M
Enterprise Value/EBITDA(ttm)
-1.13
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
179.51
Price to Book(mrq)
--
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
-46.57%
Operating Margin(ttm)
-39358.88%
Profit Margin(ttm)
-20974.16%
Return on Equity(ttm)
-699.93%
Return on Invested Capital(ttm)
-602.45%
Return on Assets(ttm)
-301.82%
Income Statement
Revenue(ttm)
941.00K
Revenue Per Share(ttm)
0.02
Gross Profit(ttm)
467.00K
EBITDA(ttm)3
-45.25M
Net Income Available to Common(ttm)
-370.37M
Diluted EPS(ttm)
-1.27K
Share Statistics
Beta (5Y Monthly)
1.02
52-Week Change
-99.15%
S&P 500 52-Week Change
12.87%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
41.30M
Dividend Yield
0.00%
Float4
34.19M
% Held by Insiders
17.22%
% Held by Institutions
18.63%
Balance Sheet
Total Cash(mrq)
124.05M
Total Cash Per Share(mrq)
3.00
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
40.03%
Quick Ratio(mrq)
39.67%
Book Value Per Share(mrq)
-3.78
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.96
Free Cash Flow(ytd)
-10.34M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.